Presentation is loading. Please wait.

Presentation is loading. Please wait.

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery  Ricardo L Levin, MD, Marcela A Degrange, MD, Gustavo F Bruno,

Published byEdith Dennis Modified over 6 years ago

Similar presentations

Presentation on theme: "Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery  Ricardo L Levin, MD, Marcela A Degrange, MD, Gustavo F Bruno,"— Presentation transcript:

1 Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery 
Ricardo L Levin, MD, Marcela A Degrange, MD, Gustavo F Bruno, MD, Carlos D Del Mazo, MD, Daniel J Taborda, MD, Jorge J Griotti, MD, Fernando J Boullon, MD  The Annals of Thoracic Surgery  Volume 77, Issue 2, Pages (February 2004) DOI: /S (03)

2 Fig 1 Evolution of vasoplegic patients. (MB = methylene blue; VS = vasoplegic syndrome.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

3 Fig 2 Number of vasoplegic patients with vasopressor requirements. (MB = methylene blue.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

4 Fig 3 Therapeutic options in postoperative vasoplegia. (NO = nitric oxide.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

Download ppt "Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery  Ricardo L Levin, MD, Marcela A Degrange, MD, Gustavo F Bruno,"

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus
POSSUM scoring system as an instrument of audit in lung resection surgery  Alessandro Brunelli, MD, Aroldo Fianchini, MD, Rosaria Gesuita, MS, Flavia Carle,

POSSUM scoring system as an instrument of audit in lung resection surgery  Alessandro Brunelli, MD, Aroldo Fianchini, MD, Rosaria Gesuita, MS, Flavia Carle,
Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,

Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,
New-onset sustained ventricular tachycardia and fibrillation early after cardiac operations  John A Yeung-Lai-Wah, MBChB, Anzhen Qi, MD, Elizabeth McNeill,

New-onset sustained ventricular tachycardia and fibrillation early after cardiac operations  John A Yeung-Lai-Wah, MBChB, Anzhen Qi, MD, Elizabeth McNeill,
Lily E. Johnston, MD, MPH, Jennifer L. Kirby, MD, PhD, Emily A

Lily E. Johnston, MD, MPH, Jennifer L. Kirby, MD, PhD, Emily A
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.
Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival  J. Hunter Mehaffey, MD, Lily E. Johnston, MD,

Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival  J. Hunter Mehaffey, MD, Lily E. Johnston, MD,
Immunology and failure of valved allografts in children

Immunology and failure of valved allografts in children
CTSNet: a unique educational vehicle

CTSNet: a unique educational vehicle
Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V

Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V
What is the marginal cost for marginal risk in cardiac surgery?

What is the marginal cost for marginal risk in cardiac surgery?
Heterotopic pancreas of the esophagus masquerading as Boerhaave’s syndrome  R.Thomas Temes, MD, Michael J Menen, MD, Michael S Davis, MD, Stuart B Pett,

Heterotopic pancreas of the esophagus masquerading as Boerhaave’s syndrome  R.Thomas Temes, MD, Michael J Menen, MD, Michael S Davis, MD, Stuart B Pett,
Coronary artery operation in patients after breast cancer therapy

Coronary artery operation in patients after breast cancer therapy
François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD 

François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD 
Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis

Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis
Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass–induced injury  Maurice Beghetti, MD, Philip E Silkoff, Marlova Caramori, MD,

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass–induced injury  Maurice Beghetti, MD, Philip E Silkoff, Marlova Caramori, MD,
Morbidity and mortality after 94 extrapleural pneumonectomies for empyema  Yuji Shiraishi, MD, Yutsuki Nakajima, MD, Akira Koyama, MD, Keiichiro Takasuna,

Morbidity and mortality after 94 extrapleural pneumonectomies for empyema  Yuji Shiraishi, MD, Yutsuki Nakajima, MD, Akira Koyama, MD, Keiichiro Takasuna,
Public policy and the practicing physician

Public policy and the practicing physician
12-Month Outcome After Cardiac Surgery: Prediction by Troponin T in Combination With the European System for Cardiac Operative Risk Evaluation  Giovanna.

12-Month Outcome After Cardiac Surgery: Prediction by Troponin T in Combination With the European System for Cardiac Operative Risk Evaluation  Giovanna.

Similar presentations

Ads by Google